BOTOX is indicated for the treatment of blepharospasm associated with dystonia, including benign essential blepharospasm, hemifacial spasm or VIIth nerve disorders in patients 12 years or older.
BOTOX is indicated for the correction of strabismus in patients 12 years of age or older.
BOTOX is indicated for the treatment of spasmodic torticollis (cervical dystonia) in adults.
BOTOX is indicated for the treatment of dynamic equinus foot deformity due to spasticity in paediatric cerebral palsy patients, two years of age or older.
BOTOX is indicated in the management of focal spasticity, of the upper limbs associated with stroke in adults.
BOTOX is indicated in the management of focal spasticity, of the lower limbs associated with stroke in adults.
BOTOX is indicated for the treatment of severe, primary axillary hyperhidrosis that is inadequately managed by topical agents. The objective of treatment is to reduce sweating to a physiologically normal level which patients find tolerable. Anhidrosis is not the target.
BOTOX is indicated for the temporary treatment of glabellar lines associated with corrugator and/or procerus muscle activity and crow's feet associated with orbicularis oculi muscle activities in adult patients below 65 years of age.
BOTOX is indicated for the temporary improvement in the appearance of moderate to severe forehead lines in adults.
BOTOX is indicated for the prophylaxis of headaches in adults with chronic migraine (headaches on at least 15 days per month of which at least 8 days are with migraine).
BOTOX is indicated for the treatment of overactive bladder with symptoms of urinary incontinence, urgency, and frequency, in adults who have an inadequate response to or are intolerant of an anticholinergic medication.
BOTOX is indicated for the treatment of urinary incontinence due to neurogenic detrusor overactivity e.g., spinal cord injury (SCI) or multiple sclerosis (MS) in adults who have an inadequate response to or are intolerant of anticholinergic medications.